Stay updated on Clinical Trial of IL-2 + Nivolumab in RCC
Sign up to get notified when there's something new on the Clinical Trial of IL-2 + Nivolumab in RCC page.

Latest updates to the Clinical Trial of IL-2 + Nivolumab in RCC page
- Check5 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3; this change seems to be a software version update and does not modify the study details or how users interact with the page.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.4.2 was added, and the broad government funding operating-status notice was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check41 days agoChange DetectedNew government funding notice banner now appears at the top of the page. The page revision tag was updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check48 days agoChange DetectedGlossary display is now shown and UI metadata was updated to include 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data' with a new 'Revision: v3.4.0' note. The previous items 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check62 days agoChange DetectedA minor site revision was applied: Revision v3.3.4 was added and Revision v3.3.3 was removed.SummaryDifference0.1%

- Check84 days agoChange DetectedLocations sections updated to include Michigan, Minnesota, and Ohio sites, replacing the prior locations blocks. Page revision updated from v3.3.2 to v3.3.3.SummaryDifference0.4%

Stay in the know with updates to Clinical Trial of IL-2 + Nivolumab in RCC
Enter your email address, and we'll notify you when there's something new on the Clinical Trial of IL-2 + Nivolumab in RCC page.